BARDA orders more smallpox and mpox vaccines from Bavarian Nordic
BARDA is continuing its drive to secure more smallpox vaccines, inking another order with manufacturer Bavarian Nordic.
The Danish manufacturer received an order from BARDA for $120 million-worth of its smallpox/mpox vaccine on Thursday. Around $96 million of the contracted vaccines will be manufactured this year but will only partly restore the bulk product used during the mpox outbreak last year.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.